ServiceUpdated on 14 August 2025
R&D of Generyc & Hybryd Drugs
About
From concept to market — we turn your ideas into successful products.
We offer a full-service approach to the development of generic and hybrid drugs, including:
-
Formulation development — over 40 ready-to-market formulations in our portfolio
-
Clinical trials — BA/BE/PK studies with in-house clinical and bioanalytical capabilities
-
Regulatory support — preparation and submission of documents to CTIS
-
Bioanalytical services — precise and fast LC-MS/MS analysis in compliance with EMA/FDA guidelines
Our expertise:
-
Cardiovascular and neurological drugs
-
Flexible service models: full-cycle development or standalone solutions tailored to your needs
With our experience and integrated facilities, we ensure speed, accuracy, and compliance — every step of the way.
Type
- Development
- Consulting
Applies to
- Pharmaceutical industry
- Laboratory industry
- Health innovation
Attached files
Organisation
Similar opportunities
Service
- Development
- Laboratory industry
- Pharmaceutical industry
Kseniya Tymko
Business Development Director at Pharmbiotest Poland Ltd
Grudziadz, Poland
Service
- Others
- Pharmaceutical industry
Kseniya Tymko
Business Development Director at Pharmbiotest Poland Ltd
Grudziadz, Poland
Expertise
ADVANCING PROTEIN DEGRADERS PROTACS or MOLECULAR GLUES
Constantin TAMVAKOPOULOS
Research Director Pharmacology, Center of Clinical, Experimental Surgery & Translational Research, at Pharmacolgy Tamvakopoulos Lab
Athens, Greece